Equities

Austco Healthcare Ltd

AHC:ASX

Austco Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.245
  • Today's Change-0.008 / -2.97%
  • Shares traded747.09k
  • 1 Year change+30.95%
  • Beta0.9375
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Austco Healthcare Ltd grew revenues 38.28% from 42.06m to 58.15m while net income improved 213.37% from 2.26m to 7.08m.
Gross margin52.74%
Net profit margin12.17%
Operating margin9.72%
Return on assets13.29%
Return on equity20.40%
Return on investment18.42%
More ▼

Cash flow in AUDView more

In 2024, Austco Healthcare Ltd increased its cash reserves by 190.09%, or 8.88m. The company earned 11.35m from its operations for a Cash Flow Margin of 19.51%. In addition the company generated 8.84m cash from financing while 11.06m was spent on investing.
Cash flow per share0.0303
Price/Cash flow per share9.83
Book value per share0.123
Tangible book value per share0.0655
More ▼

Balance sheet in AUDView more

Austco Healthcare Ltd has a Debt to Total Capital ratio of 14.83%, a higher figure than the previous year's 0.49%.
Current ratio2.38
Quick ratio1.75
Total debt/total equity0.1741
Total debt/total capital0.1483
More ▼

Growth rates in AUD

Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 196.64%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
EPS growth(5 years)53.51
EPS (TTM) vs
TTM 1 year ago
190.45
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.